+1 (704) 266-3234

Antiglaucoma Drugs Global Market Report 2020 Including: 1) By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others 2) By Disease Condition Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma 3) By Type: Hospital Prescription Drugs, Over-the Counter Drugs Covering: Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare, Johnson & Johnson

Published on: Aug 2019 | From USD $4000 | Published By: THE BUSINESS RESEARCH COMPANY | Number Of Pages: 200

The antiglaucoma drug market consists of sales of antiglaucoma drugs which are used in the treatment of glaucoma. Glaucoma is a disease in which the optic nerve is damaged resulting into irreversible loss of vision and it is often associated with increased pressure of the fluid in eye. The market comprises of segments such as alpha agonists, beta blockers, prostaglandins, combined medication and other. The market does not include the sale of biologics used for the treatment of glaucoma.

The global antiglaucoma drugs market was valued at about $15.62 billion in 2018 and is expected to grow to $20.57 billion at a CAGR of 7.1% through 2022.

The antiglaucoma drugs market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. The North American Market is the largest market for antiglaucoma drugs and is expected to continue to do so during the forecast period.

Incidence of glaucoma increases with age and due to increase in the geriatric population worldwide, governments are launching initiatives to promote awareness on glaucoma and other eye disorders. For instance, the Vision Health initiative by Centers for Disease Control and Prevention (CDC) in the USA aimed to prevent eye disorders including glaucoma and improve the overall eye health. In Australia, the government funded an eye screening program as part of its Vision 2020 initiative to promote awareness and prevent vision loss among the population suffering from glaucoma and other eye disorders. These government initiatives will stimulate the awareness among the people on glaucoma driving the market for anti-glaucoma drugs.

Anti-glaucoma drugs are facing the risk of patent expiration in the USA and Europe. For instance, travaprost and bimatoprost, which are used in the treatment of glaucoma, will lose its patent in 2021. This will result in the launch of generic form of the drugs that are priced lower than branded drugs thereby reducing the overall market growth.

Companies in the antiglaucoma drugs market are developing combination therapies in the treatment of glaucoma disease due to their ability to lower intraocular pressure in glaucoma patients. Most of the combinations therapies are fixed dose drugs as it offers patient the ease of consumption when compared to non-fixed combinations. In 2017, Alcon launched a combination drug, Simbrinza which is fixed combination of Brinzolamide and Brimonidine, to help patients in reducing the intake of multiple drugs for glaucoma.

To get an antiglaucoma drug approved by the United States Food and Drug Administration (USFDA), drug should have comparable intraocular pressure (IOP) lowering efficacy and benefit-to-hazard ration with respect to the benchmark drug. In 2018, Rhopressa (netarsudil) Ophthalmic Solution by Aerie Pharmaceuticals Inc., was approved by the US FDA considering its ability to lower IOP when compared to benchmarked drugs for glaucoma in the market.

In 2018, Astellas Pharma Inc. acquired Quethera Ltd., a gene therapy company based in the UK. With this acquisition, Astellas has gained authority over Quethera's ophthalmic gene therapy program which focuses on developing novel treatment for ocular diseases such as glaucoma.

Major players in the market are Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare and Johnson & Johnson.

Antiglaucoma Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiglaucoma Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others 2) By Disease Condition Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma 3) By Type: Hospital Prescription drugs, Over-the counter drugs

Companies Mentioned: Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare, Johnson & Johnson

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Antiglaucoma Drugs Market Characteristics
3. Antiglaucoma Drugs Market Size And Growth
3.1. Global Antiglaucoma Drugs Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Antiglaucoma Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Antiglaucoma Drugs Market Segmentation
4.1. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Combined Medication
Others
4.2. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Open-Angle Glaucoma
Angle-Closure Glaucoma
Normal-Tension Glaucoma
Congenital Glaucoma
Other Types Of Glaucoma
4.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospital Prescription drugs
Over-the counter drugs
5. Antiglaucoma Drugs Market Regional And Country Analysis
5.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Antiglaucoma Drugs Market
6.1. Asia-Pacific Antiglaucoma Drugs Market Overview
6.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Antiglaucoma Drugs Market
7.1. China Antiglaucoma Drugs Market Overview
7.2. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Antiglaucoma Drugs Market
8.1. India Antiglaucoma Drugs Market Overview
8.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Antiglaucoma Drugs Market
9.1. Japan Antiglaucoma Drugs Market Overview
9.2. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Antiglaucoma Drugs Market
10.1. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Antiglaucoma Drugs Market
11.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Antiglaucoma Drugs Market
12.1. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Antiglaucoma Drugs Market
13.1. Western Europe Antiglaucoma Drugs Market Overview
13.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Antiglaucoma Drugs Market
14.1. UK Antiglaucoma Drugs Market Overview
14.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Antiglaucoma Drugs Market
15.1. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Antiglaucoma Drugs Market
16.4. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Antiglaucoma Drugs Market
17.1. Eastern Europe Antiglaucoma Drugs Market Overview
17.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Antiglaucoma Drugs Market
18.1. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Antiglaucoma Drugs Market
19.1. North America Antiglaucoma Drugs Market Overview
19.2. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Antiglaucoma Drugs Market
20.1. USA Antiglaucoma Drugs Market Overview
20.2. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Antiglaucoma Drugs Market
21.1. South America Antiglaucoma Drugs Market Overview
21.2. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Antiglaucoma Drugs Market
22.1. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Antiglaucoma Drugs Market
23.1. Middle East Antiglaucoma Drugs Market Overview
23.2. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Antiglaucoma Drugs Market
24.1. Africa Antiglaucoma Drugs Market Overview
24.2. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles
25.1. Antiglaucoma Drugs Market Competitive Landscape
25.2. Antiglaucoma Drugs Market Company Profiles
25.2.1. Aerie Pharmaceuticals, Inc
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. ALLERGAN
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Novartis AG
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Abbott Healthcare
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Johnson & Johnson
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market
27. Antiglaucoma Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Antiglaucoma Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: China, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: China, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: India, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: India, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: Japan, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: Japan, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: Australia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Australia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Indonesia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: Indonesia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: South Korea, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: South Korea, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Western Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: Western Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: UK, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: UK, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: Germany, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: Germany, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: France, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: France, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: Russia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: Russia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: North America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: North America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: USA, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: USA, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: South America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: South America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: Brazil, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Brazil, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Middle East, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Middle East, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Africa, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Africa, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 46: Aerie Pharmaceuticals, Inc Financial Performance
Table 47: ALLERGAN Financial Performance
Table 48: Novartis AG Financial Performance
Table 49: Abbott Healthcare Financial Performance
Table 50: Johnson & Johnson Financial Performance


Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: China, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: China, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: India, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: India, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: Japan, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: Japan, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: Australia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Australia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Indonesia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: Indonesia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: South Korea, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: South Korea, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Western Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: Western Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: UK, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: UK, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: Germany, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: Germany, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: France, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: France, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: Russia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: Russia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: North America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: North America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: USA, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: USA, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: South America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: South America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: Brazil, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Brazil, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Middle East, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Middle East, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Africa, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Africa, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 46: Aerie Pharmaceuticals, Inc Financial Performance
Figure 47: ALLERGAN Financial Performance
Figure 48: Novartis AG Financial Performance
Figure 49: Abbott Healthcare Financial Performance
Figure 50: Johnson & Johnson Financial Performance

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4000
USD $6000
USD $8000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.